By leveraging select pharmacogenomic tools, physicians can minimize off-target effects of medications for their rare disease patients and support improved health outcomes while minimizing unintended consequences from adverse drug reactions or dosages.
The post Pharmacogenomics Can Ease Burden On Doctors Treating Patients With Rare Diseases appeared first on MedCity News.
